Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...

(Reuters) -Pfizer (PFE) said on Monday it would acquire drug developer Metsera (MTSR) in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the ...

(Reuters) - Cybersecurity firm Netskope is now aiming for a valuation of up to $7.26 billion in its U.S. initial public offering after raising the proposed price range, it said on Tuesday, ...

ITR Income Tax Return Deadline Extension 2025 Live: Latest updates on due date and filing status. Last year, when the deadline was July 31, about 7.28 crore income tax returns were filed. This time, 6 ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook The exterior of CATL's headquarters in the eastern Chinese city of Ningde. Credit: CATL Chinese ...

"There is no room for rules," Niesmann+Bischoff said a few years ago, at the launch of the iSmove line of compact motorhomes designed to feel and live like true liners but in a much smaller footprint.

Tata Group's automobile manufacturing arm, Tata Motors, on Friday, 5 September, announced that the company is cutting the prices of its passenger vehicles by up to ₹1.45 lakh effective from 22 ...

Fans of reMarkable's series of notepad-like note-taking E-Ink tablets have something new to get excited about today: a new version of the devices called the reMarkable Paper Pro Move, which takes the ...

Internet infrastructure company Cloudflare said it recently blocked the largest recorded volumetric distributed denial-of-service (DDoS) attack, which peaked at 11.5 terabits per second (Tbps). In ...

Pfizer is doing well enough to pay down debt while sustaining its generous dividend. Oncology and specialty drugs are driving growth. The stock has a high ceiling heading into next year. But Pfizer's ...

Marking an important moment in the current expansion's life cycle, FFXIV patch 7.3 will put a closure to Dawntrail’s arc while bringing new content to the table. In preparation for this update, the ...